Maize gene ZmRAVL1 and functional site and use thereof

Patent metadata

Field	Value
Publication number	US-12559764-B2
Application number	US-202017617142-A
Country	US
Kind code	B2
Filing date	Jun 9, 2020
Priority date	Jun 10, 2019
Publication date	Feb 24, 2026
Grant date	Feb 24, 2026

Abstract

The present invention relates to a maize gene ZmRAVL1 and a functional site and use thereof. The present invention locates the functional site for controlling the leaf angle phenotype to 240 bp by fine-mapping, and the insertion and deletion of this region lead to different leaf angle phenotypes. The present invention demonstrates that an inbred line improved with an excellent natural variation from the teosinte can increase maize yield under dense planting and broaden the source of elite alleles available in plant breeding. The present invention demonstrates that a reduced ZmRAVL1 expression by a genetic engineering technique (RNAi) has an influence on plant architectures, such as a reduced leaf angle, and thus it provides excellent genetic resources for genetic engineering breeding. The present invention produces favorable alleles by adopting the gene-editing technology, and thus greatly shortens the selection process of elite alleles, which provides a new idea for obtaining elite alleles available in the breeding practice. The present invention can quickly and accurately improve or produce superior inbred lines with the aid of the molecular marker-assisted selection technology, which provides the possibility of wide application of elite alleles.

First claim

What is claimed is:

1 . A method to control a plant architecture, comprising breeding plants to comprise a polynucleotide sequence and selecting the plants having reduced leaf angle,
wherein the polynucleotide sequence comprises the sequence of SEQ ID No: 1; and wherein the plant is a maize.

2 . A method for controlling a plant architecture, comprising regulating the ZmRAVL1 gene in a plant and selecting the plant having reduced leaf angle,
wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising an amino acid sequence defined by (i), or (ii): (i) the amino acid sequence set forth in SEQ ID No: 27; or (ii) an amino acid sequence having at least 95%, 96%, 97%, 98%, 98.5%, 99% or 99.5% identity with the amino acid sequence set forth in SEQ ID No: 27, wherein the regulating comprises disrupting the expression level, activity, or combination thereof of the ZmRAVL1 gene, and wherein the disrupting is achieved by knock-out or knock-down of the ZmRAVL1 gene by RNAi technology or by a genome editing system or wherein the disrupting is achieved by regulating DRL1 and/or DRL2; and wherein the plant is a maize.

3 . The method of claim 2 , wherein the disrupting is achieved by regulating expression level, activity or a combination thereof of DRL1 and/or DRL2, and/or by regulating binding of DRL1 and/or DRL2 to a target.

4 . The method of claim 2 , wherein the genome editing system is CRISPR/Cas, TALEN, or ZFN.

5 . A method of producing a transgenic plant with compact plant architecture, comprising
obtaining a transgenic plant cell with inhibited expression of the ZmRAVL1 gene or the gene products thereof compared to a wild type plant, regenerating a transgenic plant from said transgenic plant cell, and selecting the transgenic plant having reduced leaf angle, wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising an amino acid sequence defined by (i), or (ii): (i) the amino acid sequence set forth in SEQ ID No: 27; or (ii) an amino acid sequence having at least 95%, 96%, 97%, 98%, 98.5%, 99% or 99.5% identity with the amino acid sequence set forth in SEQ ID No: 27; and wherein the plant is a maize.

6 . The method according to claim 5 , wherein the transgenic plant cell is obtained by mutagenesis, gene editing, or RNA-mediated inhibition of the ZmRAVL1 gene.

7 . The method according to claim 6 , wherein the RNA-mediated inhibition consists of introducing into a plant cell a polynucleotide encoding a RNA molecule that is at least 70% complementary to at least 15 continuous nucleotides of the ZmRAVL1 gene.

8 . The method of claim 2 , wherein the ZmRAVL1 gene comprises the following sequence:
(i) the nucleotide sequence set forth in SEQ ID No: 26; (ii) a cDNA sequence of the nucleotide sequence set forth in SEQ ID No: 26; or (iii) a nucleotide sequence having at least 95%, 96%, 97%, 98%, 98.5%, 99% or 99.5% identity with the nucleotide sequence set forth in SEQ ID No: 26.

9 . The method of claim 2 , wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising an amino acid sequence defined by (i), or (ii):
(i) the amino acid sequence set forth in SEQ ID No: 27; or (ii) an amino acid sequence having at least 97%, 98%, 98.5%, 99% or 99.5% identity with the amino acid sequence set forth in SEQ ID No: 27.

10 . The method of claim 9 , wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising an amino acid sequence defined by (i), or (ii):
(i) the amino acid sequence set forth in SEQ ID No: 27; or (ii) an amino acid sequence having at least 98%, 98.5%, 99% or 99.5% identity with the amino acid sequence set forth in SEQ ID No: 27.

11 . The method of claim 10 , wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising the amino acid sequence of SEQ ID No: 27.

12 . The method of claim 5 , wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising an amino acid sequence defined by (i), or (ii):
(i) the amino acid sequence set forth in SEQ ID No: 27; or (ii) an amino acid sequence having at least 97%, 98%, 98.5%, 99% or 99.5% identity with the amino acid sequence set forth in SEQ ID No: 27.

13 . The method of claim 12 , wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising an amino acid sequence defined by (i), or (ii):
(i) the amino acid sequence set forth in SEQ ID No: 27; or (ii) an amino acid sequence having at least 98%, 98.5%, 99% or 99.5% identity with the amino acid sequence set forth in SEQ ID No: 27.

14 . The method of claim 13 , wherein the ZmRAVL1 gene encodes a ZmRAVL1 protein comprising the amino acid sequence of SEQ ID No: 27.

15 . The method of claim 8 , wherein the ZmRAVL1 gene comprises the following sequence:
(i) the nucleotide sequence set forth in SEQ ID No: 26; (ii) a cDNA sequence of the nucleotide sequence set forth in SEQ ID No: 26; or (iii) a nucleotide sequence having at least 97%, 98%, 98.5%, 99% or 99.5% identity with the nucleotide sequence set forth in SEQ ID No: 26.

16 . The method of claim 15 , wherein the ZmRAVL1 gene comprises the following sequence:
(i) the nucleotide sequence set forth in SEQ ID No: 26; (ii) a cDNA sequence of the nucleotide sequence set forth in SEQ ID No: 26; or (iii) a nucleotide sequence having at least 98%, 98.5%, 99% or 99.5% identity with the nucleotide sequence set forth in SEQ ID No: 26.

17 . The method of claim 16 , wherein the ZmRAVL1 gene comprises the following sequence:
(i) the nucleotide sequence set forth in SEQ ID No: 26; or (ii) a cDNA sequence of the nucleotide sequence set forth in SEQ ID No: 26.

Assignees

• Univ China Agricultural

Inventors

• Tian Feng
• Tian Jinge
• Wang Chenglong

Classifications

• C12Q2600/13

  Plant traits · CPC title

• C12Q1/6895 Primary

  for plants, fungi or algae · CPC title

• C12N15/8262

  involving plant development · CPC title

• C12N15/8218

  Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

• C07K14/415 Primary

  from plants · CPC title